MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Discover how genetic testing can aid in diagnosing Polyglucosan Body Myopathy Type 2, offering personalized treatment plans and vital insights for family planning.
Explore the role of genetic testing in diagnosing Pontocerebellar Hypoplasia 1C, offering early intervention, personalized treatment, and informed family planning.
Explore genetic testing in diagnosing Porokeratosis 8 and its role in personalized treatment. Understand genetic mutations and proactive management strategies.
Unlock the complexities of Primary Ciliary Dyskinesia 30 with genetic testing, enabling precise diagnosis, personalized treatments, and informed family planning.
Unlock insights into progeroid features-hepatocellular carcinoma predisposition syndrome with genetic testing, aiding early diagnosis and personalized treatment.
Explore how genetic testing aids in diagnosing Progressive Encephalopathy with DECR deficiency, focusing on early intervention, family planning, and treatment research.
Explore the role of genetic testing in diagnosing Progressive Myoclonic Epilepsy Type 7 (PME7), identifying KCNC1 mutations, and guiding personalized treatment plans.
Explore how genetic testing and the CERS1 gene mutation discovery can enhance diagnosis and treatment of Progressive Myoclonic Epilepsy Type 8.